Narcolepsy Type
📧 Sign up to get email alerts when something new happens for Narcolepsy Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304) [Phase 3]
A Phase 3 clinical trial evaluating the efficacy, safety and tolerability of ALKS 2680 in adults with Narcolepsy Type 1, not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of ALKS 2680 in adults with Narcolepsy Type 2 is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 [Phase 3]
A Phase 3 study to evaluate the efficacy and safety of ALKS 2680 in adults with Narcolepsy Type 1; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia [Phase 2]
A Phase 2 long-term extension study of ORX750 for Narcolepsy Type 1, Narcolepsy Type 2, and Idiopathic Hypersomnia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy [Phase 3]
A Phase 3 clinical trial evaluating TAK-861 for narcolepsy with cataplexy is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Decreasing Nightmares in Adults With Narcolepsy [NA]
A clinical trial to evaluate approaches to reduce nightmares in adults with narcolepsy, including Narcolepsy Type 1.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions [Phase 2, Phase 3]
This clinical trial update concerns TAK-861 for central hypersomnia, specifically Narcolepsy Type 1, across Phase 2 and Phase 3, and is curr…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
An ongoing Spanish epidemiology study is evaluating Narcolepsy Type 1 and Type 2, focusing on prevalence, clinical features, and potential r…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia [Phase 2, Phase 3]
Clinical trial update indicating ongoing long-term Phase 2/Phase 3 studies of ALKS 2680 for narcolepsy types 1 and 2 and idiopathic hypersom…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Pain Assessment in Patients With Idiopathic REM Sleep Behaviour Disorder [NA]
A clinical trial update notes a pain assessment study in patients with idiopathic REM sleep behavior disorder is recruiting. The trial is sp…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control Population
This ClinicalTrials.gov update describes a study comparing bacterial translocation and gut microbiota in Narcolepsy Type 1 patients versus a…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Extended-release Sodium Oxybate in Children [Phase 2]
A Phase 2 clinical trial evaluating an extended-release formulation of sodium oxybate in children with Narcolepsy Type 1 is currently recrui…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia [Phase 2]
This document provides a status update on a Phase 2 clinical trial evaluating ORX750 for narcolepsy type 1, narcolepsy type 2, and idiopathi…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia [NA]
A University of Sydney-sponsored clinical trial is investigating a novel approach to managing symptoms of idiopathic hypersomnia and narcole…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions [NA]
A clinical trial update shows a study exploring mind-wandering and predictive processes in narcolepsy, investigating covert REM intrusions. …
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia [NA]
ClinicalTrials.gov update for NCT06484348, investigating the interactions between food intake, daytime sleepiness, and nighttime sleep quali…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Mentalizating in Adults Suffering from Narcolepsy Type 1.
A clinical trial sponsored by University Hospital, Toulouse, is recruiting adults with Narcolepsy Type 1 to study mentalizing abilities.
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 [Phase 3]
This is a clinical trial update describing a Phase 3 study of NLS-2, mazindol extended release, for Narcolepsy Type 1 (with cataplexy), whic…